These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 304500)

  • 21. Alloantibodies to PHA-activated lymphocytes detect human Qa-like antigens.
    Gazit E; Gothelf Y; Gil R; Orgad S; Pitman TB; Watson AL; Yang SY; Yunis EJ
    J Immunol; 1984 Jan; 132(1):165-9. PubMed ID: 6606664
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro induction of HLA-restricted cytotoxic T lymphocytes against autologous Epstein-Barr Virus transformed B lymphoblastoid cell line.
    Fukukawa T; Hirano T; Sakaguchi N; Teranishi T; Tsuyuguchi I; Nagao N; Naito N; Yoshimura K; Okubo Y; Tohda H; Oikawa A
    J Immunol; 1981 May; 126(5):1697-701. PubMed ID: 6163815
    [TBL] [Abstract][Full Text] [Related]  

  • 23. T cell differentiation/maturation of CD34+ stem cells from HIV-seropositive hemophiliacs in cultured thymic epithelial fragments.
    Ruiz M; Roodman ST; Bouhasin JD; Knutsen AP
    Stem Cells; 1996 Jan; 14(1):132-45. PubMed ID: 8820959
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Antigenic properties of human leukemic cells demonstrated by allosera. -- Use of permanently cultured lymphoblastoid cell lines (B, T and "null") for detection of cytotoxic antibodies in sera of different groups of blood donors (author's transl)].
    Koubek K; Libánský J
    Cas Lek Cesk; 1979 Mar; 118(12):358-62. PubMed ID: 313248
    [No Abstract]   [Full Text] [Related]  

  • 25. Alloantisera detect HLA-A-B-C and non-HLA differentiation antigens on human thymocytes.
    Mahoney RJ; Gazit E; MacCarthy-Shanley K; Martin-Alosco S; Palomaki GE; Smith DE; Yunis EJ
    J Immunol; 1982 Dec; 129(6):2630-5. PubMed ID: 6982934
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HLA variants of human lymphoblastoid cell lines as targets for cytotoxic T cells: analysis of CTL reactivity against 2 HLA-DR variants.
    Newman W; Pious D; Gladstone P
    J Immunol; 1980 Dec; 125(6):2515-20. PubMed ID: 6968788
    [No Abstract]   [Full Text] [Related]  

  • 27. B-cell alloantigens on T lymphocytes.
    Mann DL; Sharrow SO
    Transplant Proc; 1979 Dec; 11(4):1774-5. PubMed ID: 394431
    [No Abstract]   [Full Text] [Related]  

  • 28. Immunological and serological data concerning human histocompatibility antigens (HLA) and alpha 1-microglobulin co-purified from urine.
    Dautigny A; Bernier I; Lethielleux P; Colombani J; Jollès P
    Biomedicine; 1979 Dec; 31(8):233-6. PubMed ID: 93973
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Different cytotoxic reactivity of anti-HLA A or B sera against sub-population of human lymphocytes prepared with different methods].
    Richiardi P; Crepaldi T; Curtoni ES
    G Batteriol Virol Immunol; 1980; 73(7-12):180-9. PubMed ID: 6975729
    [No Abstract]   [Full Text] [Related]  

  • 30. Requirement of HLA compatibility between T- and B-cells in mitogen-induced in vitro immunoglobulin production.
    Yata J; Kobayashi N; Shimbo T; Kakihara U; Sugahara M; Yamakura T
    J Clin Lab Immunol; 1978 Nov; 1(3):245-8. PubMed ID: 315469
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dilutions and specificity analysis of pretransplant sera.
    Iwaki Y; Terasaki PI; Park MS; Heintz R; Silberman H; Berne T
    Transplant Proc; 1979 Mar; 11(1):944-9. PubMed ID: 377726
    [TBL] [Abstract][Full Text] [Related]  

  • 32. T- and B-cells in immunologic diseases.
    Strober S
    Am J Clin Pathol; 1977 Nov; 68(5 Suppl):671-8. PubMed ID: 335878
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Previously unexplained HLA antigens of combined immunodeficiency disease due to Ia alloantigens.
    Noreen HJ; van der Hagen BA; Greenberg LJ; Kersey J; Emme L; Yunis EJ
    Transplant Proc; 1977 Dec; 9(4):1717-9. PubMed ID: 304619
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Markers of human T cell subsets identified by alloantisera.
    Ferrara GB; Strelkauskas AJ; Longo A; McDowell J; Yunis EJ; Schlossman SF
    J Immunol; 1979 Sep; 123(3):1272-7. PubMed ID: 381520
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chimerism and tolerance to host and donor in severe combined immunodeficiencies transplanted with fetal liver stem cells.
    Bacchetta R; Vandekerckhove BA; Touraine JL; Bigler M; Martino S; Gebuhrer L; de Vries JE; Spits H; Roncarolo MG
    J Clin Invest; 1993 Mar; 91(3):1067-78. PubMed ID: 8450037
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Extra reactivities detected in flow-cytometry-positive, CDC-negative crossmatches are definable HLA specificities.
    Rodey G; Bollig B; Oldfather J; Schutte L; Flye W; Phelan D
    Transplant Proc; 1987 Feb; 19(1 Pt 1):778-9. PubMed ID: 3274872
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human T-cell hybrids with HLA-restricted proliferative response to Epstein-Barr virus-infected B cells.
    Gallagher G; Stimson WH
    Immunology; 1984 Dec; 53(4):611-21. PubMed ID: 6209205
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peripheral blood B cells producing donor-specific HLA antibodies in vitro.
    Han M; Rogers JA; Lavingia B; Stastny P
    Hum Immunol; 2009 Jan; 70(1):29-34. PubMed ID: 19026703
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reactivity of alloantibodies of the Merrit B-cell system with leukemic cells and lymphoblastoid cell lines.
    Naeim F; Leibold W; Gatti R; Walford RL
    Transplant Proc; 1977 Mar; 9(1 Suppl 1):151-5. PubMed ID: 300925
    [TBL] [Abstract][Full Text] [Related]  

  • 40. B lymphocyte alloantigen specificities present on cultured lymphoblastoid cell lines.
    Honig R; Billing R; Matsuyama M; Terasaki PJ
    J Immunol; 1976 Oct; 117(4):1300-2. PubMed ID: 61996
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.